Contact
Please use this form to send email to PR contact of this press release:
Asterias’ AST-OPC1 Clinical Trial Will Continue as Planned Following Recommendation of Data Monitoring Committee
TO:
Please use this form to send email to PR contact of this press release:
Asterias’ AST-OPC1 Clinical Trial Will Continue as Planned Following Recommendation of Data Monitoring Committee
TO: